A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer’s Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging

BACKGROUND: Small aggregates (oligomers) of the toxic proteins amyloid-β (Aβ) and phospho-tau (p-tau) are essential contributors to Alzheimer’s disease (AD). In mouse models for AD or human AD brain extracts, Transcranial Electromagnetic Treatment (TEMT) disaggregates both Aβ and p-tau oligomers, an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Alzheimers Dis
Autori principali: Arendash, Gary, Cao, Chuanhai, Abulaban, Haitham, Baranowski, Rob, Wisniewski, Gary, Becerra, Lino, Andel, Ross, Lin, Xiaoyang, Zhang, Xiaolin, Wittwer, David, Moulton, Jay, Arrington, John, Smith, Amanda
Natura: Artigo
Lingua:Inglês
Pubblicazione: IOS Press 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6839500/
https://ncbi.nlm.nih.gov/pubmed/31403948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-190367
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi